This is our review of SR9009 or Stenabolic SARM is an experimental compound that is currently being researched by the TSRI or The Scripps Research Institute. Existing animal models and tests have shown that Stenabolic can greatly increase the aerobic and muscular endurance of test subjects.
Furthermore, researchers believe that this compound can help individuals suffering from physical mobility issues. A good example of such individuals are people who have been diagnosed as having morbid obesity.
Disclaimer: We are not recommending taking this product, yet simply reviewing the product based on our research. SR9009 Stenabolic is sold for research purposes only & is not approved for human use or consumption! Please do your own research before making any decisions related to SR9009 Stenabolic.
Stenabolic and degenerative diseases
Obviously, morbid obesity will greatly limit your physical movements, which will make it doubly hard for a person to gain lean muscle mass and consequently, aerobic endurance and muscular strength.
Additional conditions that may soon be treated with Stenabolic include COPD (chronic obstructive pulmonary disease, a common condition experienced by long-term smokers), congestive heart disease (another medical condition associated with poor lifestyle choices and smoking) and finally, geriatric muscle wastage, or the accelerated loss of lean muscle mass due to aging.
The history of SR9009
Stenabolic has an interesting history by itself. First developed by the researcher Prof. Thomas Burris, the compound was first administered to mice in the hopes of improving their physical performance.
The results were fascinating: even without additional exercise or massive changes to their diets, the test mice exhibited a 50% increase in their ability to run, all the while developing more muscles volume and a leaner physique.
This brings us to the big question – what in the world does Stenabolic actually do in the body?
Apparently, science has hit upon a compound that not only selectively binds to androgen receptors, causing the expression of genes that benefit the bones and muscles, but also a compound that is capable mimicking the actual effects of aerobic exercise! How did Stenabolic pull this one off? Upon closer examination, the compound binds to Rev-erbα (NR1D1) which is a protein encoded by the NR1D1 gene.
It is a transcriptional repressor and also influences how the body utilizes fat and glucose/sugar available to the body.
The role of Rev-erbα
The Rev-erbα protein is expressed extensively in the liver, muscles, bones, and other tissues in the body. It is not surprising then, that when Stenabolic binds to the Rev-erbα protein, it can cause so much benefit to the body as it influences how energy is ported and utilized in large tissue groups!
The creator of this compound stated that basically, animals who have undergone treatment with this compound were able to develop musculature similar to musculature of athletes who were training hard.
SR9009 has also been found to affect the body’s natural clock, which regulates activities of the body around the 24-hour period we are all accustomed to.
The main theory of why SR9009 does what it does is that the Rev-erbα protein activates an increased production of mitochondria in affected cells.
The mitochondria is the powerhouse of cells and is responsible for sustaining normal cell activity from growth, to flourishing to death. Flawed mitochondria are also affected by the secondary effects of Stenabolic as they are authorized, too.
SR9009 and metabolic conditions
These breakthrough findings on SR9009 means there is finally a compound that can specifically be administered to individuals that are suffering from the degenerative effects of metabolic syndrome.
Metabolic issues can and will affect a wide range of systems in the body, as it deals with how energy is used and stored in the body. Even small fluctuations and defects can cause organ damage in people afflicted with metabolic syndrome, so it really does make sense for human trials to begin as soon as possible with this remarkable new compound.
Theoretically, how will Stenabolic affect the human body once administered?
Since this compound affects the Rev-erbα protein, which is highly and widely expressed throughout the body, the first thing that a patient will notice will be a sudden surge of muscular energy.
If the opportunity is taken, this surge can be translated to higher muscular endurance with increased exercise and better nutrition.
Since a person’s muscle cells will have much higher mitochondrial counts, energy levels will rapidly increase, allowing the patient to exceed current aerobic exercise limits.
Fat loss and aerobic capability
This has been proven by animal tests, where mice administered with SR9009 were able to run longer distances at quicker times compared to before they were given Stenabolic. This is one of the simpler and more obvious effects of this experimental new SARM.
But what about fat loss? Why does Stenabolic reduce the volume of fat being stored by the body? The answer lies in how energy is ported after Stenabolic is administered.
Stenabolic increases the metabolic rate by an average of 5% and in the process, prevents the conversion of glucose to fat. Increased oxidization of fat and its subsequent conversion to free energy also helps reduce the storage of adipose tissue.
To a person who requires a better muscular physique, this is obviously a plus if Stenabolic is administered by a healthcare professional in a therapeutic setting.
The secondary effects of Stenabolic are interlinked: when the patient’s body is storing less fat, the body also produces less LDL (low-density lipoproteins), and this directly helps reduce the incidence of atherosclerosis or the hardening of the major arteries connected to the heart. A healthy heart is obviously a requirement if you wish to maintain a healthy and strong physique.
One must not sacrifice the various organ systems just to get a better, muscular physique.
Theoretical dosing for humans
In a medical-therapeutic setting, Stenabolic may be used to improve a person’s capacity to move about, while boosting metabolic levels and protecting the heart from any on-going damage caused by less a less than ideal diet. Theoretical dosing for humans is 20 to 30 milligrams of Stenabolic per day.
For better results of course, the patient must make an effort to maximize physical activity and improve one’s diet, focusing on higher protein intake throughout the cycle.
To condition the body fully to the new SARM, it is also theoretically recommended to administer the experimental substance once every two to four hours, but never going over the maximum dosing indicated for every 24 hour period.
This way, the effects of Stenabolic will be present in the muscles for most of the day, giving the patient the main advantages (muscular strength and endurance) when it is required.